Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H25NO |
Molecular Weight | 271.3972 |
Optical Activity | ( + ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CCCC[C@]13CCN(C)[C@H]2CC4=CC=C(OC)C=C34
InChI
InChIKey=MKXZASYAUGDDCJ-NJAFHUGGSA-N
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1
Molecular Formula | C18H25NO |
Molecular Weight | 271.3972 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:42 UTC 2023
by
admin
on
Fri Dec 15 15:04:42 UTC 2023
|
Record UNII |
7355X3ROTS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000181821
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
CFR |
21 CFR 341.14
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
CFR |
21 CFR 341.74
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
WHO-VATC |
QN07XX59
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
WHO-VATC |
QR05DA09
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
WHO-ATC |
R05DA09
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
NDF-RT |
N0000182149
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
WHO-ATC |
N07XX59
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
||
|
NCI_THESAURUS |
C2199
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1180503
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
C62022
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
751452
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
m4227
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | Merck Index | ||
|
166
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
N0000181819
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | Uncompetitive NMDA Receptor Antagonists [MoA] | ||
|
4470
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
DTXSID3022908
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
3056
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
125-71-3
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
SUB07051MIG
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
204-752-2
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
CHEMBL52440
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
N0000182147
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | Sigma-1 Receptor Agonists [MoA] | ||
|
842
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
DB00514
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
6953
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
7355X3ROTS
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
Dextromethorphan
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
7355X3ROTS
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
3289
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
ALTERNATIVE | RxNorm | ||
|
DEXTROMETHORPHAN
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
100000092321
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
D003915
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
5360696
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY | |||
|
236146
Created by
admin on Fri Dec 15 15:04:42 UTC 2023 , Edited by admin on Fri Dec 15 15:04:42 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Metabolizing reaction by CYP2D6: O-demethylation
Pharmacological action: Antitusive agent
MAJOR
Unidentified
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->WEAK INHIBITOR |
Rat. Prodrug of dextrorphan, which is the actual mediator of most of its dissociative effects through acting as a more potent NMDA receptor antagonist than dextromethorphan itself.
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
Rat
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
SECONDARY METABOLITE CYP3A4 ALSO INVOLED IN PRIMARY
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|